Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Earnings Up, Life Sciences Revenues Decline

NEW YORK, April 24 - PerkinElmer reported today earnings of $2.3 million and a slight increase in revenues for the first quarter.


These earnings, which came to $.02 per share, contrasted with the company's net loss of $147.3 million, or $1.17 per share, for the same period last year, which was widened due to changes in accounting rules.


Total sales for the company totaled $358.4 million, compared to $346.3 million in the same period last year.   While revenues in the company's optoelectronics and analytical instruments areas grew, revenue declined in life sciences.


R&D expenses for the quarter came to $20.9 million, compared to $21.8 million for the year-ago quarter.


The company had a total of $129.8 million in cash and cash equivalents at the end of March, compared to $170.4 million on March 31, 2002.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.